Peer-reviewedCC BY 4.0Signal Transduction and Targeted Therapy
HLA allele DRB1*01:03: the genetic link to neutralizing IL-10 antibodies in inflammatory bowel disease
- 1Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany
- 2FAU Profilzentrum Immunmedizin (FAU I-MED), FAU Erlangen-Nürnberg, Erlangen, Germany
Related
- Novel recombinant bovine papular stomatitis virus expressing foot-and-mouth disease virus-like particles elicits neutralizing antibodies in cattle.
- Vimentin neutralizing antibody ameliorate inflammatory bowel disease by inhibiting fibrosis and inflammatory cell death
- Cross‐Neutralizing and Broadly Neutralizing Human Antibodies Against Nonenveloped Viruses
- B cell response to HCMV gH/UL116 elicits neutralizing and FcγR-activating antibodies
- Structure-guided vaccination elicits broadly neutralizing antibodies targeting the HIV-1 silent face
BibTeX
@article{mattner2026allele,
title = {{HLA allele DRB1*01:03: the genetic link to neutralizing IL-10 antibodies in inflammatory bowel disease}},
author = {Jochen Mattner},
journal = {Signal Transduction and Targeted Therapy},
year = {2026},
month = oct,
doi = {10.1038/s41392-026-03005-8},
url = {https://doi.org/10.1038/s41392-026-03005-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - HLA allele DRB1*01:03: the genetic link to neutralizing IL-10 antibodies in inflammatory bowel disease
AU - Jochen Mattner
PY - 2026
DA - 2026/10/27
JO - Signal Transduction and Targeted Therapy
DO - 10.1038/s41392-026-03005-8
UR - https://doi.org/10.1038/s41392-026-03005-8
SN - 2095-9907
SN - 2059-3635
ER -